GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Country] NL — basisverzekering will not cover it, here is what i tried — 18 comments in the full submission. View in context.
206
c/glp1eu·submitted 3 days ago by u/pavel_kimani

[Country] NL — basisverzekering will not cover it, here is what i tried

Countrybranch of 6 comments

NL — basisverzekering will not cover it, here is what i tried, and I am aware this is a minority view on this board. Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them. The variation between pharmacies inside my own country was larger than the…

Read the full submission and all 18 comments →

This branch

6 comments, started 2 days ago
u/mei_cardoso14 points·2 days ago

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/still_here_20265 points·2 days ago

Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.

replysharereportpermalink
u/zeynep_weiss2 points·2 days ago

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

replysharereportpermalink
u/pavel_kimaniOP4 points·2 days ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/zaid_eriksen4 points·2 days ago

The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.

replysharereportpermalink
u/ignacio_silva2 points·2 days ago

the EMA authorises, member states decide who pays

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.